CV Advisors LLC

Position in NVS — Novartis AG

CIK 1872254 Aventura, FL

Position in NVS

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$595,536

New position

Shares Held

3,800

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#816

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CV Advisors LLC holds $4,492,270 across 6 Drug Manufacturers - General names. NVS ranks #5 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	10,000	$1,285,000
2	ABBV	AbbVie Inc.	3,600	$905,904
3	BMY	Bristol Myers Squibb Co	12,000	$691,440
4	PFE	Pfizer Inc	26,200	$630,896
5	NVS	Novartis AG This page	3,800	$595,536
6	JNJ	Johnson & Johnson	1,510	$383,494

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$595,536	3,800	—	Shares	Sole	2026-07-21
No filing history on record for this holder in this stock.